Sterling Clarren

Sterling K. Clarren is one of the world's leading researchers into Fetal Alcohol Spectrum Disorder (FASD), an umbrella term encompassing fetal alcohol syndrome (FAS), alcohol-related neurodevelopmental disorder, static encephalopathy:alcohol exposed and penatal alcohol exposed. He was the Robert A. Aldrich Professor of Pediatrics at the University of Washington School of Medicine in Seattle, Washington, and doctor for the university's FAS diagnostic and prevention clinic prior to becoming the CEO and Scientific Director of the Canada FASD Research Network.

Clarren has studied FASD since 1975 and helped to establish the definitions of FAS and FAE. He wrote the first article on the neuropathology of FAS, and developed the first non-human primate model for studying dose-response. He has testified about FASD before the United States Congress and the Washington State Legislature.

Education

Clarren received his bachelor's from Yale University and his MD from the University of Minnesota. His postgraduate training was in pediatrics, and fellowship training was in neuroembryology, teratology, and dysmorphology at the University of Washington.

Professional life

Clarren is a fellow of the American Academy of Pediatrics, the American Association for the Advancement of Science, a past president of the FAS study group for the Research Society on Alcoholism, past president of the West Coast Teratology Society, and a member of the Society for Pediatric Research, New York Academy of Science, the Teratology Society.

He has received funding from the National Institute on Alcohol Abuse and Alcoholism, the Centers for Disease Control, the Glaser Foundation, and the March of Dimes. He has published over 100 scholarly papers.

Clarren is currently working as a clinical professor for the Centre for Community Child Health Research at the Child and Family Research Institute in Vancouver, B.C., Canada.

Papers

Books and chapters

References

This article is issued from Wikipedia - version of the 2/19/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.